GBT logo

GBT Current Assets

Annual Current Assets

$801.97 M
+$169.81 M+26.86%

December 31, 2021


Summary


Performance

GBT Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGBTbalance sheetmetrics:

Quarterly Current Assets

$640.01 M
-$35.64 M-5.27%

June 30, 2022


Summary


Performance

GBT Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherGBTbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

GBT Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+26.9%+21.9%
3 y3 years+65.1%-4.0%
5 y5 years+147.3%+172.5%

GBT Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-20.2%at low
5 y5-yearat high-21.7%-20.2%-23.6%
alltimeall timeat high-99.5%-20.2%-93.4%

Global Blood Therapeutics Current Assets History

DateAnnualQuarterly
Jun 2022
-
$640.01 M(-5.3%)
Mar 2022
-
$675.65 M(-15.8%)
Dec 2021
$137.24 M(+49.4%)
$801.97 M(+64.0%)
Sep 2021
-
$488.86 M(-6.9%)
Jun 2021
-
$524.86 M(-6.0%)
Mar 2021
-
$558.13 M(-11.7%)
Dec 2020
$91.84 M(-45.4%)
$632.16 M(+6.3%)
Sep 2020
-
$594.66 M(+0.1%)
Jun 2020
-
$594.03 M(+5.2%)
Mar 2020
-
$564.47 M(-10.1%)
Dec 2019
$168.10 M(+27.5%)
$628.00 M(+2.0%)
Sep 2019
-
$615.80 M(-7.6%)
Jun 2019
-
$666.76 M(+43.2%)
Mar 2019
-
$465.49 M(-4.2%)
Dec 2018
$131.86 M
$485.78 M(+23.9%)
Sep 2018
-
$392.18 M(-16.5%)
DateAnnualQuarterly
Jun 2018
-
$469.54 M(-15.2%)
Mar 2018
-
$553.85 M(+70.8%)
Dec 2017
$32.41 M(-38.4%)
$324.31 M(+41.1%)
Sep 2017
-
$229.77 M(-2.2%)
Jun 2017
-
$234.85 M(-5.4%)
Mar 2017
-
$248.32 M(+65.8%)
Dec 2016
$52.62 M(+2234.4%)
$149.77 M(-32.3%)
Sep 2016
-
$221.27 M(-5.5%)
Jun 2016
-
$234.10 M(+71.5%)
Mar 2016
-
$136.54 M(-8.8%)
Dec 2015
$2.25 M(+4.2%)
$149.72 M(-6.8%)
Sep 2015
-
$160.73 M(+279.0%)
Jun 2015
-
$42.41 M(-11.6%)
Mar 2015
-
$47.99 M(-10.4%)
Dec 2014
$2.16 M(-11.6%)
$53.59 M
Dec 2013
$2.45 M
-

FAQ

  • What is Global Blood Therapeutics annual total current assets?
  • What is the all time high annual current assets for Global Blood Therapeutics?
  • What is Global Blood Therapeutics annual current assets year-on-year change?
  • What is Global Blood Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Global Blood Therapeutics?
  • What is Global Blood Therapeutics quarterly current assets year-on-year change?

What is Global Blood Therapeutics annual total current assets?

The current annual current assets of GBT is $801.97 M

What is the all time high annual current assets for Global Blood Therapeutics?

Global Blood Therapeutics all-time high annual total current assets is $801.97 M

What is Global Blood Therapeutics annual current assets year-on-year change?

Over the past year, GBT annual total current assets has changed by +$169.81 M (+26.86%)

What is Global Blood Therapeutics quarterly total current assets?

The current quarterly current assets of GBT is $640.01 M

What is the all time high quarterly current assets for Global Blood Therapeutics?

Global Blood Therapeutics all-time high quarterly total current assets is $801.97 M

What is Global Blood Therapeutics quarterly current assets year-on-year change?

Over the past year, GBT quarterly total current assets has changed by +$115.15 M (+21.94%)